Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: Preliminary report

Investigative Radiology

Volumn 34, Issue 2, 1999, Pages 156-159

  Jinkins, J Randy ^a   Williams, Robert F ^a   Xiong, Lin ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Intrathecal gadopentetate dimeglumine injection; MR; MR myelography cisternography; Rabbit

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CERVICAL SPINAL CORD; CISTERNOGRAPHY; CONTRAST ENHANCEMENT; DRUG DIFFUSION; FEMALE; GRAY MATTER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

EID: 0033033105     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199902000-00009     Document Type: Article

References (18)

1. Niendorf HP, Haustein J, Cornelius I, Alhassan A, Claub W. Safety of gadolinium-DTPA: Extended clinical experience. Mag Reson Med 1991;22:222-228.
2. Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Safety and tolerance after intravenous administration of 0.3 mmol/Kg Gd-DTPA, results of a randomized, controlled clinical trial. Invest Radiol 1991;26:8221-5223.
3. Goldstein HA, Kashanian FK, Blumetti RF, et al. Safety assessment of gadopentetate dimeglumine in U.S., clinical trials. Radiology 1990; 174:17-23.
4. Di Chiro G, Knop RH, Girton MR, et al. MR cisternography and myelography with Gd-DTPA in monkeys. Radiology 1985;157: 373-377.
5. Allard M, Kien P, Caille JM, Bonnemain B, Simonnet G. Brain distribution of MTI contrast media in rats after intracisternal injection. J Neuroradiol 1987;14:383-387.
6. Ray DE, Cavanagh JB, Nolan CC, Williams SCR. Neurotoxic effects of gadopentetate dimeglumine: Behavioral disturbance and morphology after intracerebroventricular injection in rats. Am J Neuroradiol 1996;17:365-373.
7. Skalpe IO, Tang GJ. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Invest Radiol 1997;32:140-148.
8. Siebner HR, Grafin von Einsiedel H, Conrad B. Magnetic resonance ventriculography with gadolinium DTPA: Report of two cases. Neuroradiology 1997;39:418-422.
9. Winkler SS, Sackett JF. Explanation of metrizamide brain penetration: A review. J Comput Assist Tomogr 1980;4:191-193.
10. Rapoport SI. Sites and functions of the blood-brain barrier. In: Blood-Brain Barrier in Physiology and Medicine. New York: Raven Press, 1976;43-86.
11. Drayer BP, Rosenbaum AE. Metrizamide brain penetrance. Acta Radiol (S) 1977; 280-293.
12. Rall DP, Oppelt WW, Patlak CS. Extracellular space of brain as determined by diffusion of inulin from the ventricular system. Life Sci 1962;2:43-48.
13. Oldendorf WH, Davson H. Brain extracellular space and the sink action of cerebrospinal fluid. Arch Neurol 1967;17:196-205.
14. Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med 1977;296:1393-1398.
15. Davson H. The blood-brain barrier. J Physiol 1976;255:1-28.
16. Zeng QY, Xiong L, Jinkins JR, Liu Z, Fan Z. Intrathecal gadolinium-enhanced MR myelography: A pilot study in human patients. Radiology 1997;205:486.
17. Sackett JF, Strother CM. Computer tomography and subarachnoid metrizamide for evaluation of cerebrospinal fluid flow. Acta Radiol (S) 1977;355:338-344.
18. Hiratsuka H, Keigo FM, Kodai O, Takasato Y, Matsutaira T, Yutaka I. Modification of periventricular hypodensity in hydrocephalus with ventricular reflux in metrizamide CT cisternography. J Comput Assist Tomogr 1979;3:204-208.